US Medical Affairs - GI Oncology Summer Intern (Doctoral) jobs in United States
cer-icon
Apply on Employer Site
company-logo

AstraZeneca · 10 hours ago

US Medical Affairs - GI Oncology Summer Intern (Doctoral)

AstraZeneca is seeking PhD and PharmD students for a 12-week internship role at their Gaithersburg, MD site. The intern will analyze medical insights, develop scientific materials for medical education, and explore technologies to enhance medical affairs within the Oncology GI team.

BiopharmaBiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Analyze and synthesize medical insights from multiple sources to inform medical strategy and tactics
Develop external-facing scientific materials to support ongoing medical education efforts
Explore internal technologies to enhance medical affairs efficiency and impact within the USMA- Oncology GI team

Qualification

PhD in life sciencesPharmD in pharmaceuticalsOncology research experienceAnalytical skillsPublic speakingPresentation designPresentation skillsCollaboration

Required

PhD and PharmD students studying life sciences and/or pharmaceuticals
Strong scientific background is required
Candidates must have an expected graduation date after August 2026
US Work Authorization is required at time of application
Ability to report onsite to Gaithersburg, MD site 3 days per week

Preferred

Analytical and presentation skills are preferred
Prior oncology research experience is a plus
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

AstraZeneca

company-logo
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor.

Funding

Current Stage
Public Company
Total Funding
$5.26B
2024-07-30Post Ipo Debt· $1.51B
2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B

Leadership Team

leader-logo
Pascal Soriot
Executive Director and Chief Executive Officer
leader-logo
Aradhana Sarin
Group CFO and Executive Director
linkedin
Company data provided by crunchbase